公司资料
InVivo Therapeutics 股价、新闻与催化剂
- 股票代码:
- NVIV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 NVIV 的收盘价变动背景。
公司概览
业务概览
InVivo Therapeutics is a medical technology company focused on spinal cord injury and neurotrauma-related devices or therapies. Its business has centered on nervous-system repair rather than classic therapeutics.
所在地与行业分类
InVivo Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
商业模式特征
The company depends on product or therapy development, clinical progress, and the ability to maintain a viable path in a difficult indication. Investors usually watch regulatory updates, commercialization strategy, and capital runway.
生物医药行业定位
InVivo occupies a niche neurorepair position within healthcare innovation. It is not a typical biotech drug stock, but it remains tied to a high-unmet-need clinical area.
未来催化剂
- InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone. The market is mainly focused on residual value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。